- Home
- EVC vs VXRT Comparison
EVC vs VXRT Comparison
Compare EVC & VXRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- VXRT
- Stock Information
- Founded
- EVC 1996
- VXRT N/A
- Country
- EVC United States
- VXRT United States
- Employees
- EVC N/A
- VXRT N/A
- Industry
- EVC Broadcasting
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVC Industrials
- VXRT Health Care
- Exchange
- EVC Nasdaq
- VXRT Nasdaq
- Market Cap
- EVC 185.4M
- VXRT 200.3M
- IPO Year
- EVC 2000
- VXRT N/A
- Fundamental
- Price
- EVC $2.32
- VXRT $0.81
- Analyst Decision
- EVC Hold
- VXRT Strong Buy
- Analyst Count
- EVC 1
- VXRT 2
- Target Price
- EVC $1.75
- VXRT $3.00
- AVG Volume (30 Days)
- EVC 219.2K
- VXRT 1.1M
- Earning Date
- EVC 10-31-2024
- VXRT 10-31-2024
- Dividend Yield
- EVC 8.64%
- VXRT N/A
- EPS Growth
- EVC N/A
- VXRT N/A
- EPS
- EVC N/A
- VXRT N/A
- Revenue
- EVC $1,126,331,000.00
- VXRT $13,928,000.00
- Revenue This Year
- EVC N/A
- VXRT $67.68
- Revenue Next Year
- EVC N/A
- VXRT N/A
- P/E Ratio
- EVC N/A
- VXRT N/A
- Revenue Growth
- EVC 65.95
- VXRT 577.76
- 52 Week Low
- EVC $1.33
- VXRT $0.52
- 52 Week High
- EVC $4.41
- VXRT $1.54
- Technical
- Relative Strength Index (RSI)
- EVC 67.75
- VXRT 48.09
- Support Level
- EVC $2.05
- VXRT $0.77
- Resistance Level
- EVC $2.15
- VXRT $0.83
- Average True Range (ATR)
- EVC 0.08
- VXRT 0.05
- MACD
- EVC 0.02
- VXRT -0.00
- Stochastic Oscillator
- EVC 96.73
- VXRT 32.00
About EVC Entravision Communications Corporation
Entravision Communications Corp is a global advertising solutions, media, and technology company. Its operations encompass integrated marketing and media solutions, comprised of television, radio, and digital properties and data analytics services. The company operates in television broadcasting, audio broadcasting, and digital media segments. The Company's digital segment, whose operations are located in Europe, Latin America, Asia, the United States, and Africa. The Company's television and audio operations reach and engage U.S. Hispanics in the United States.
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.